<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.1.2" -->
<rss version="0.92">
<channel>
	<title>Parathyroid Cancer</title>
	<link>http://parathyroid-cancer.com</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Mon, 09 Jun 2008 14:37:53 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Parathyroid cancer is a rare disease in which malignant (cancer) cells form in the tissues of a parathyroid gland</title>
		<description>
The parathyroid glands are four pea-sized organs found in the neck near the thyroid gland. The parathyroid glands make parathyroid hormone (PTH or parathormone). PTH helps the body use and store calcium to keep the calcium in the blood at normal levels. 
A parathyroid gland may become overactive and make ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/parathyroid-cancer-is-a-rare-disease-in-which-malignant-cancer-cells-form-in-the-tissues-of-a-parathyroid-gland/</link>
			</item>
	<item>
		<title>PARATHYROID CANCER</title>
		<description>
The term cancer does not refer to a single disease, but rather to more than 100 individual diseases characterized by the uncontrolled growth of cells within the body. Most normal cells grow, reproduce and die in an orderly, controlled fashion. However, cancer cells grow and divide endlessly, crowding out nearby ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/parathyroid-cancer-4/</link>
			</item>
	<item>
		<title>First treatment for serious complications of kidney disease, parathyroid cancer - Updates - Brief Article</title>
		<description>
Patients who experience debilitating consequences of chronic kidney disease and parathyroid cancer now have a first-of-its-kind treatment option.
Sensipar (cinacalcet) was approved in March 2004 to treat secondary hyper-parathyroidism in patients with chronic kidney disease who are on dialysis. In secondary hyperparathyroidism, elevated levels of parathyroid hormone are associated with changes ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/first-treatment-for-serious-complications-of-kidney-disease-parathyroid-cancer-updates-brief-article/</link>
			</item>
	<item>
		<title>Naoyoshi Onoda</title>
		<description>
Kana Ogisawa2, Tetsuro Ishikawa2, Chiemi Takenaka1, 2, Hideki Tahara3, Masaaki Inaba3, Tsutomu Takashima2 and Kosei Hirakawa2
(1)           Department of Oncology, Institute of Geriatrics and Medical Science, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan
 
 (2)          Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan
 
(3)           Department of ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/naoyoshi-onoda/</link>
			</item>
	<item>
		<title>Huge parathyroid carcinoma: Clinical considerations and literature review</title>
		<description>
Background
Parathyroid carcinoma is a rare malignancy, with an incidence of 0.5 to 4% of all cases of primary hyperparathyroidism. Surgery is the only curative treatment.
Case presentation
We report the case of a 66-year-old man referred for a large suspicious substernal goitre associated with severe hypercalcemia due to hyperparathyroidism. After normalization of ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/huge-parathyroid-carcinoma-clinical-considerations-and-literature-review-2/</link>
			</item>
	<item>
		<title>FDA Approves</title>
		<description>
First in a New Class of Drugs to Treat Hyperparathyroidism Associated With Renal Failure and in Patients With Parathyroid Cancer
FDA has approved Sensipar (cinacalcet), a drug to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, and hypercalcemia in patients with parathyroid cancer. 
Cinacalcet is the first drug ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/fda-approves/</link>
			</item>
	<item>
		<title>Huge parathyroid carcinoma: Clinical considerations and literature review</title>
		<description>
Maria Grazia Chiofalo,1 Francesco Scognamiglio,1 Simona Losito,3 Secondo Lastoria,4 Ugo Marone,1 and Luciano Pezzullo.
1Department of Surgical Oncology, National Cancer Institute of Naples, Naples, Italy
2Unit of Thyroid and Parathyroid Surgery, National Cancer Institute of Naples, Naples, Italy
3Department of Pathology, National Cancer Institute of Naples, Naples,  Italy
4Department of Nuclear Medicine, National ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/huge-parathyroid-carcinoma-clinical-considerations-and-literature-review/</link>
			</item>
	<item>
		<title>New Treatment Option For Life-Threatening Symptom Of Parathyroid Cancer</title>
		<description>
This drug therapy could provide a new and effective medical treatment option for patients with inoperable parathyroid carcinoma (cancer). 
“Patients with inoperable parathyroid cancer typically have to contend with extremely elevated levels of calcium in their blood, which can lead to mental confusion, dehydration, kidney damage and ultimately death,” said ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/new-treatment-option-for-life-threatening-symptom-of-parathyroid-cancer/</link>
			</item>
	<item>
		<title>What Is It?</title>
		<description>
Parathyroid cancer, also called parathyroid carcinoma, is a very rare cancer that develops in the parathyroid glands, two pairs of pea-sized glands located next to the thyroid in the front of the neck. The parathyroid glands produce parathyroid hormone (PTH), a chemical that enters the bloodstream and raises calcium levels ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/what-is-it/</link>
			</item>
	<item>
		<title>PARATHYROID CANCER</title>
		<description>
Thyroid cancer represents a unique biological tumor where even with the high incidence of distant metastases, the overall prognosis is not as poor as many other human cancers. The overall long-term survival in patients presenting initially with distant metastasis is approximately 50%. The overall incidence of distant metastases varies between ...</description>
		<link>http://parathyroid-cancer.com/2008/06/09/parathyroid-cancer-3/</link>
			</item>
</channel>
</rss>
